Philip Morris International Inc.

Philip Morris International Inc. (PM) Market Cap

Philip Morris International Inc. has a market capitalization of $277.88B.

Price: $178.29

3.30 (1.89%)

Market Cap: 277.88B

NYSE · time unavailable

CEO: Jacek Olczak

Sector: Consumer Defensive

Industry: Tobacco

IPO Date: 2008-03-17

Website: https://www.pmi.com

Philip Morris International Inc. (PM) - Company Information

Market Cap: 277.88B|Sector: Consumer Defensive

Company Profile

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Analyst Sentiment

79%
Strong Buy

From 15 Active Polls

1Y Forecast: $189.60

▲ +6.3% Potential Upside

Consensus Target Metrics

Low Bound

$168

Median

$195

High Bound

$205

Average

$190

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$189.60
▲ +6.34% Upside
Low Target
$168.00
-6% Risk
Median Target
$195.00
9% Mid
High Target
$205.00
15% Max
Consensus
Buy
17 / 25 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)277,875258,397249,743252,545283,576246,666187,024188,777157,444
Enterprise Value ($M)324,373304,895293,706298,590330,900291,802228,503233,741201,707
Price to Earnings Ratio (P/E)25.1126.5029.1618.1523.3322.92-80.7515.3116.36
Price/Earnings-to-Growth Ratio (PEG)2.612.593.272.13
Price to Sales Ratio (P/S)6.7025.4724.1023.2927.9726.5219.2719.0516.63
Price to Book Ratio (P/B)-30.03-27.85-24.99-23.14-23.70-22.63-15.92-19.47-16.16
Price to Free Cash Flow Ratio (P/FCF)26.05-343.6158.5661.6492.79-327.1450.2263.7136.94
Enterprise Value to Sales (EV/Sales)30.0528.3427.5332.6331.3723.5423.5821.30
Enterprise Value to EBITDA (EV/EBITDA)18.2871.0565.1862.8178.9672.7352.6556.5052.05
Debt to Equity Ratio2.62-5.60-4.89-4.59-4.30-4.55-3.89-5.08-5.04

PM Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$178.29
Intrinsic Value$136.61
Market Alignment
Overvalued by 23.4%relative to calculated intrinsic value
9.00%
Exp: 7%7%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$18.52B
Perpetuity TV Value$348.48B
Discounted TV (PV)$147.20B
TV Weighting %61.4%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 PHILIP MORRIS INTERNATIONAL INC (PM) — Investment Overview

🧩 Business Model Overview

Philip Morris International (PM) manufactures and sells nicotine products through a global distribution network, earning revenue primarily from the sale of cigarettes and smoke-free alternatives (notably heated tobacco products). The economics are driven by a blend of (1) device-and-consumable style recurring purchasing for smoke-free formats and (2) established, high-volume cigarette routes to market.

A key structural feature is consumer persistence: once adult consumers adopt a specific product category (and, for heated tobacco, a device ecosystem), the ongoing need to purchase consumable units creates a durable demand base. That stickiness is reinforced by PM’s scale in manufacturing, logistics, and marketing/retailer execution within regulated adult-use channels.

💰 Revenue Streams & Monetisation Model

  • Cigarettes (core volume engine): Transactional purchases with mature demand, monetised through pricing, mix, and effective excise pass-through where allowed.
  • Heated tobacco (device ecosystem + consumables): More “repeat-like” economics versus cigarettes because consumables must be replenished, supporting steadier long-run volume stability when adoption holds.
  • Other nicotine products: Supplementary offerings that can help broaden the portfolio as regulation and consumer preferences evolve.

Margin drivers typically include: (i) product and geography mix (including the relative contribution of smoke-free versus cigarettes), (ii) manufacturing cost discipline and scale benefits, (iii) procurement leverage across tobacco and indirect inputs, and (iv) the regulatory treatment of different formats—especially excise/tax differentials and marketing restrictions.

🧠 Competitive Advantages & Market Positioning

PM’s competitive position rests on moats that are less about “innovation narratives” and more about execution under tight regulation and a consumer-category adoption dynamic.

  • Switching costs (within product ecosystems): Adoption of heated tobacco ties consumers to consumable formats and often to specific devices. While regulation and competition can influence transitions, the ecosystem structure tends to slow consumer churn versus switching between unrelated categories.
  • Regulatory and compliance moat (high barrier to entry): Tobacco products operate in a fragmented, jurisdiction-specific regulatory environment. PM’s capability in product stewardship, approvals, and ongoing compliance reduces the likelihood of prolonged disruption relative to smaller or less-experienced peers.
  • Scale cost advantages: Large-scale manufacturing, procurement, and logistics support lower unit costs and resilience during excise/tax changes and volume pressures.
  • Intangible assets (portfolio expertise): The company’s accumulated know-how in operating regulated adult-use markets—supply chain planning, demand forecasting, and retailer execution—supports steadier commercialization of category shifts.

COMPETITIVE BENCHMARKING:

  • British American Tobacco (BAT): Major global peer competing in cigarettes and smoke-free products, with its own heated tobacco and vapour strategy.
  • Japan Tobacco International (JTI): Competes strongly in heated tobacco formats and markets with different regulatory constraints.
  • Imperial Brands: Competes across cigarettes and reduced-risk offerings, often with a different geography mix and regulatory exposure profile.

Contrast in industry focus: PM is primarily oriented toward heated tobacco adoption at scale in international markets, positioning its portfolio around regulatory pathways for reduced-risk products while maintaining cigarettes as the cash-generating base. This contrasts with peers whose reduced-risk mixes may be more weighted toward vapour or other categories depending on country rules and product approvals.

🚀 Multi-Year Growth Drivers

  • Smoke-free category shift: Over a 5–10 year horizon, total market growth is less about expanding nicotine users and more about migration within nicotine consumption—from cigarettes toward alternatives where permitted and where adults find acceptable utility.
  • Regulatory-defined “winners” within reduced-risk categories: Jurisdictions that sustain differentiated treatment (tax and marketing rules) for approved smoke-free formats can support adoption economics and help preserve category momentum.
  • Operating leverage and cost discipline: Scale manufacturing and procurement can help protect cash generation even if unit volumes face pressure.
  • Portfolio resilience across geographies: Diversification across multiple markets can smooth volatility in local excise schedules, enforcement intensity, and consumer response.

The investment case is best framed as a cash-flow durability story plus a managed transition: maintain mature-cash engines while scaling reduced-risk formats where regulatory frameworks and consumer acceptance support sustainable unit economics.

⚠ Risk Factors to Monitor

  • Regulatory reversals and excise parity: Policies that reduce or eliminate differential treatment of smoke-free products can compress unit economics and slow adoption.
  • Technological and consumer preference shifts: Increased share movement toward alternative nicotine technologies (e.g., other reduced-risk categories) can undermine the expected transition profile.
  • Litigation and health-policy outcomes: Legal exposure and evolving regulatory standards can create cost and uncertainty around product marketing and health claims.
  • Illicit trade and enforcement gaps: Counterfeit or untaxed product inflows can pressure pricing and volumes, especially in jurisdictions with weaker controls.
  • Capital intensity and execution risk: Device and product ecosystem scale-up requires disciplined working capital management and supply chain continuity.

📊 Valuation & Market View

Tobacco equities are typically valued on cash-flow durability and the credibility of capital returns rather than rapid top-line growth. Market pricing often reflects:

  • Free cash flow conversion: Sustained conversion supports dividends and share repurchases.
  • Multiple sensitivity to regulatory risk: When markets perceive rising regulatory uncertainty, equity valuations commonly compress; clearer policy pathways can support higher confidence in cash flows.
  • Mix and margin expectations: The expected trajectory of smoke-free versus cigarettes influences earnings quality and long-term margins.

In practice, investors often triangulate between EV/EBITDA (for operating stability), free-cash-flow yield (for capital return capacity), and earnings resilience under excise and regulatory scenarios.

🔍 Investment Takeaway

PM’s long-term thesis centers on durable cash generation from cigarettes combined with a regulated, ecosystem-based approach to smoke-free growth. The core moats—scale cost advantages, ecosystem switching dynamics in heated tobacco, and a regulatory/compliance capability that lowers execution risk—support resilience through industry transitions, provided that excise treatment and reduced-risk regulatory pathways remain navigable.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for PM.

businesswire.com2026-06-03

Counterfeit Cigarettes Drive EU Illicit Market Above 10% for First Time Since 2014

STAMFORD, CT--(BUSINESS WIRE)--A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% year-on-year in 2025, reaching levels not seen in over a decade, with counterfeit cigarettes playing an increasingly significant role across member states. Philip Morris International (PMI) (NYSE: PM) reiterates its call for a coordinated response to illicit trade in Europe, built on evidence-based regulation.

gurufocus.com2026-06-03

Counterfeit Cigarettes Drive EU Illicit Market Above 10% for First Time Since 2014

A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% y

gurufocus.com2026-06-02

PMI Cuts Outlook After $500 Million Write-Down As BAT Stays Cautious

Philip Morris International (PM) cut its profit forecast for this fiscal year after taking a $500 million write-down tied to its Canadian affiliate, Rothmans, B

reuters.com2026-06-02

Philip Morris cuts annual profit forecast on cost pressure, weak pricing power

Philip Morris cut its annual profit forecast on Tuesday, with CEO Jacek Olczak citing margin pressure due to higher ​energy costs from the Iran conflict and currency ‌swings, at a time when consumers rein in spending.

wsj.com2026-06-02

Philip Morris to Post $500 Million Impairment on Canada Affiliate

Philip Morris International said it is booking a roughly $500 million impairment charge in the second quarter to reduce the carrying value of its investment in Canadian affiliate Rothmans Benson & Hedges, or RBH.

gurufocus.com2026-06-02

Philip Morris International Participates in 2026 dbAccess Global Consumer Conference; Updates 2026 Full-Year Diluted EPS Forecast for Currency and Non-Cash Impairment Only

Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE: PM) Group CEO PMI, Jacek Olczak, will address investors today at the 2026 dbAccess Global Co

businesswire.com2026-06-02

Philip Morris International Participates in 2026 dbAccess Global Consumer Conference; Updates 2026 Full-Year Diluted EPS Forecast for Currency and Non-Cash Impairment Only

STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE: PM) Group CEO PMI, Jacek Olczak, will address investors today at the 2026 dbAccess Global Consumer Conference in Paris at 11:15 a.m. CET (5:15 a.m. ET), including discussion of the following topics: PMI's continued expectation of a strong full-year performance, notably driven by the broad-based momentum of our international multicategory smoke-free business, led by IQOS. Recent heat-not-burn category.

gurufocus.com2026-06-01

Is PM Overvalued? DCF Says Worth $90

On June 01, 2026, we delve into the DCF analysis for Philip Morris International Inc (PM), a company that has shown varied price performance recently. The stock

seekingalpha.com2026-05-29

Philip Morris: The Pullback Is A Gift For Long-Term Investors

Philip Morris: The Pullback Is A Gift For Long-Term Investors

barrons.com2026-05-26

7 Dividend Stocks to Beat Inflation

Historically, energy stocks have performed the best when inflation spikes.

fool.com2026-05-26

Market Crash: 3 Stocks I'd Buy Without Hesitation

Walmart, Realty Income, and PMI are all resilient blue chip stocks.

gurufocus.com2026-05-26

IQOS One of the Most Valuable Global Brands, According to Kantar's BrandZ 2026 Ranking

Philip Morris International's (PMI) (NYSE: PM) IQOS, the #1 tobacco heating system1, has been listed for the first time as one of the top 100 most valuable bra

businesswire.com2026-05-26

IQOS One of the Most Valuable Global Brands, According to Kantar's BrandZ 2026 Ranking

STAMFORD, Conn.--(BUSINESS WIRE)--Philip Morris International's (PMI) (NYSE: PM) IQOS, the #1 tobacco heating system1, has been listed for the first time as one of the top 100 most valuable brands in the world in Kantar's BrandZ 2026 Most Valuable Global Brands. This ranking solidifies IQOS's global momentum and its emergence as a culturally relevant, iconic brand for adult nicotine users seeking better alternatives to cigarettes. According to the BrandZ 2026 Most Valuable Global Brands, IQOS a.

fool.com2026-05-24

The Best Dividend Stocks to Buy and Hold Forever

The list of companies you can trust indefinitely is quite short. Here are three of them.

fool.com2026-05-22

3 Dividend Stocks to Hold for the Next 20 Years

Mastercard's advantageous position in the global payments space points to continued high dividend growth in the years ahead. It's unclear how long Microsoft's AI growth catalyst will last, but don't rule out its potential to keep on raising its dividend.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"PM reported revenue of $10.15B and net income of $2.44B in the most recent quarter (EPS: $1.56). On a YoY basis, revenue grew +9.1% (from $9.30B), but net income declined -9.3% (from $2.69B). QoQ, revenue eased -2.1% (from $10.36B) while net income rose +13.9% (from $2.14B). Profitability is mixed: net margin improved QoQ to ~24.0% (from ~20.7%), but remains below the YoY level (~28.9%), implying cost/mix or one-offs helped quarter-over-quarter results but not on a year-over-year basis. From a balance sheet perspective, total assets stayed broadly stable (~$68.9B) while equity remains negative, though it improved meaningfully versus the prior quarter (from about -$8.0B to -$5.3B). Dividend continuity appears intact (recent quarterly dividend $1.47; yield previously ~0.9% and currently not reported in the ratio set). Shareholder returns look muted: the stock is down -1.68% over the last year, which weighs on total return, partially offset by dividends. Valuation sentiment is supportive: the consensus price target of ~$187.6 vs. ~$157.8 implies ~19% upside."

Revenue Growth

Positive

Revenue was +9.1% YoY ($9.30B → $10.15B) but -2.1% QoQ ($10.36B → $10.15B), suggesting growth is positive but momentum softened in the most recent quarter.

Profitability

Fair

Net margin improved QoQ to ~24.0% (from ~20.7%) with net income +13.9% QoQ, but YoY net income fell -9.3% and margin declined vs. ~28.9% a year ago, indicating profitability is still not consistently improving year-over-year.

Cash Flow Quality

Fair

No cash-flow statement data provided in the history. Dividend has continued (e.g., $1.47/quarter recently), but payout ratio was previously above 100% in 2025-12-31, implying coverage may have been tight at times; buybacks are not evidenced here.

Leverage & Balance Sheet

Neutral

Equity is negative (e.g., -$5.3B latest; improved vs. -$8.0B prior quarter), and liabilities exceed assets. While there was improvement in equity QoQ, the capital structure remains fragile.

Shareholder Returns

Caution

1y price performance is slightly negative (-1.68% 1y_change). Dividend yield has been ~0.8%–0.9% historically, but without evidence of meaningful buybacks, total shareholder return appears modest.

Analyst Sentiment & Valuation

Positive

Consensus target of ~$187.6 vs. ~$157.8 current implies ~19% upside, suggesting analyst sentiment/valuation support despite near-term earnings volatility.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

PM delivered a strong Q1 2026 despite U.S. ZYN shipment/inventory timing effects and challenging combustible cigarette comps. Net revenues topped $10B (+9% reported; +2.7% organic) and adjusted EPS rose 16% to $1.96, supported by currency tailwinds and better-than-expected tax. Profit quality was the key highlight: adjusted gross margin expanded +70 bps and adjusted operating income margin gained +40 bps to >41%. International smoke-free materially outperformed, with smoke-free gross margin expanding +210 bps to 70% on +11.9% volume growth, +15.8% revenue growth, and +19.4% gross profit growth—led by IQOS. Combustibles held up with +8.5% pricing, and organic gross margins expanded +190 bps even with volumes down. Guidance was reconfirmed currency-neutral: organic net revenue +5% to +7% and organic OI +7% to +9%, plus updated currency-tailwind EPS $8.36–$8.51. Q&A stressed maintaining premium ZYN pricing discipline and expecting better ZYN dynamics post-comps and innovation ramp.

AI IconGrowth Catalysts

  • International smoke-free: IQOS close to +11% adjusted in-market sales growth, supporting +19.4% gross profit growth
  • Multi-category acceleration: ZYN and VEEV contributing to smoke-free mix; VEEV IMS volumes almost doubled and VEEV joint #1 close-pot brand in Europe (Nielsen, 19 markets) per Q4 '25 estimate
  • Pricing-driven resilience in combustibles: +8.5% combustible pricing supporting low single-digit organic top line and low-to-mid single-digit organic gross profit growth despite negative cigarette volume lapping effects

Business Development

  • ZYN launches: ZYN in Portugal and Kenya
  • ZYN in Europe momentum: reached estimated joint #1 position in Europe (Nielsen) per prepared remarks (as stated, with specific Nielsen figure indiscernible in transcript)
  • VEEV in Egypt (launch/footprint stated as part of smoke-free expansion): VEEV in Egypt; VEEV expanded footprint to 49 markets
  • ZYN in Taiwan not applicable; IQOS in Taiwan: after launch in Q4 '25, Taiwan exited March with ~8% share; Taipei share over 7% in Q2 post-launch (company-stated milestones)
  • Regulatory process: FDA nicotine pouch pilot program application still under active scientific review; IQOS reauthorized prior version as a modified risk tobacco product; engagement re: IQOS ILUMA

AI IconFinancial Highlights

  • Net revenues: >$10B (+9% reported; +2.7% organic) vs expectations for broadly flat delivery
  • Adjusted gross profit: +10% to $6.9B; +3.8% organic and +70 bps organic gross margin expansion
  • Adjusted operating income: +10% to $4.2B; close to +1% organic growth; worldwide adjusted operating income margins expanded +40 bps to >41%
  • Adjusted diluted EPS: +16% to $1.96 (includes $0.18 currency tailwind from positive transactional impact and weaker USD); effective tax rate slightly better than expected
  • International smoke-free: gross profit and OCI each ~+10% organic and ~+16% in dollar terms
  • Smoke-free organic performance: +11.9% volume growth, +15.8% net revenue growth, +19.4% gross profit growth; smoke-free gross margin expanded +210 bps to 70%
  • International combustible: volumes -5.1%, organic net revenues +1%, gross profit +3.9% organic; gross margins expanded +190 bps organically

AI IconCapital Funding

    AI IconStrategy & Ops

    • Supply chain/cost management: approximately $150 million of gross cost efficiency realized in Q1
    • SG&A investment posture: investing in control program, scale and innovation; Q2 likely stronger YoY investment, with moderation expected in H2 and SG&A progression expected organically at or below net revenue growth
    • U.S. operational build-out: Aurora facility progressively increasing initial operations; additional manufacturing and commercial investment for ZYN innovation launches
    • Alternative it not burn technology: IQOS alternative bonds/rollout began with initial key city launches in Italy and commenced national rollout during the quarter

    AI IconMarket Outlook

    • FY 2026 reconfirmation (currency-neutral): broadly stable shipment volumes; organic net revenue growth +5% to +7%; organic operating income growth +7% to +9%; currency-neutral adjusted diluted EPS growth +7.5% to +9.5%
    • Updated adjusted diluted EPS forecast: $8.36 to $8.51 (includes forecast currency tailwind of $0.25 at prevailing rates); implies +10.9% to +12.9% growth in dollar terms
    • Q2 2026 outlook: adjusted diluted EPS $2.02 to $2.07; HTU shipment volume 40B to 42B; mid-single-digit organic net revenue growth and solid operating income progression despite continued investment

    AI IconRisks & Headwinds

    • U.S. shipment/inventory headwinds: channel inventory overhang end of 2025 largely normalized in Q1, impacting shipments vs consumer offtake
    • ZYN promotional/financial comparison effects: Q1 comparison includes Q1 2025 with close to no price promotion and significant inventory rebuild exiting supply constraints; also increased investment this quarter
    • Combustible volume softness: cigarette volumes declined at the high end of expectations; lapping exceptional +1.1% growth in Q1 2025 due to temporary factors (Indonesia, Russia, Italy, Spain) plus higher illicit consumption in certain markets and Mexico excise increase in January
    • Regulatory uncertainty and timing: FDA failure to fast-track reviews; nicotine pouch application under active scientific review; potential timing impact on innovation rollouts and financial contributions
    • Macro/energy and geopolitical uncertainty: Middle East conflict affecting travel retail shipments and certain regional markets; increased energy/transport/input costs monitored for consumer behavior shifts

    Q&A: Analyst Interest

    • Smoke-free international margins: priority to optimize supply chain at high gross margins. Management linked margin strength to IQOS performance, ongoing price increases (close to 3% on smoke-free) and portfolio value, while emphasizing volume maximization remains central because IQOS higher dollar/unit economics plus growth still drive profitability.
    • U.S. ZYN confidence for H2 and willingness to sacrifice near-term profitability. Management cited H1/Q2 base effects (last year Q2 reloading; almost no promo in Q2 2025 raising revenue per can), normalization in Q2/Q3, one-off free can effect removal, and forthcoming innovation expected to improve the second half as capacity ramps.
    • IQOS strength vs expectations and profitability drivers. Management attributed Q1 outperformance primarily to IQOS’s unique differentiated proposition and franchise, citing consistent ~75% category share. They provided Italy as an example of post-flavor-ban adaptation with double-digit growth and city-level share recovery, tying profitability to product success plus pricing/productivity and continued investment.

    Sentiment: POSITIVE

    Note: This summary was synthesized by AI from the PM Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

    📋 Official Regulatory 10-K / 10-Q SEC Filings

    Direct authenticated documentation links to audited SEC database reports for PM.

    SEC EDGAR Live Feed
    Loading financial data and tables...
    📁

    SEC Filings (PM)

    © 2026 Stock Market Info — Philip Morris International Inc. (PM) Financial Profile